Please use this identifier to cite or link to this item:
https://ahro.austin.org.au/austinjspui/handle/1/20797| Title: | The World Association of Radiopharmaceutical and Molecular Therapy position statement on the initial radioiodine therapy for differentiated thyroid carcinoma. | Austin Authors: | Dizdarevic, S;Tulchinsky, M;McCready, V R;Mihailovic, J;Vinjamuri, S;Buscombe, J R;Lee, Sze Ting ;Frangos, S;Sathekge, M;Siraj, Q;Choudhury, P;Bom, H;Franceschi, M;Ugrinska, A;Paez, D;Hussain, R;Mailman, J;Luster, M;Virgolini, I | Affiliation: | Department of Nuclear Medicine, University Hospital Marburg, Marburg, Germany Department of Nuclear Medicine, Cambridge University Hospitals, Cambridge, UK Department of Imaging and Nuclear Medicine, Brighton and Sussex University Hospitals NHS Trust, Brighton and Sussex Medical School, Royal Sussex County Hospital, Brighton, UK Department of Nuclear Medicine, Royal Liverpool University Hospital, Liverpool, UK Radiology Department, Nuclear Medicine Section, Penn State University, Milton S. Hershey Medical Center, USA Nuclear Medicine and Diagnostic Imaging Section, Division of Human Health, International Atomic Energy Agency, Vienna, Austria Department of Nuclear Medicine, Medical University of Innsbruck, Austria Department of Molecular Imaging and Therapy, Austin Health, Heidelberg, Victoria, Australia Australia School of Cancer Medicine, La Trobe University, Heidelberg, Australia Department of Nuclear Medicine, Oncology Institute of Vojvodina, Sremska Kamenica, University of Novi Sad, Faculty of Medicine, Novi Sad, Serbia Department of Nuclear Medicine, University of Pretoria and Steve Biko Academic Hospital, Pretoria, South Africa Department of Nuclear Medicine, Rajiv Gandhi Cancer Institute and Research Centre, Delhi, India Department of Nuclear Medicine, Asian Regional Cooperative Council for Nuclear Medicine (ARCCNM), Chonnam National University Medical School, Gwangju, South Korea World Association of Radiopharmaceutical and Molecular Therapy (WARMTH), Oakland, CA, USA Department of Oncology and Nuclear Medicine, Sestre Milosrdnice, UHC, Zagreb, School of Medicine, University of Zagreb, Zagreb, Croatia, Faculty of Medicine, University of Osijek, Osijek, Croatia Institute of Pathophysiology and Nuclear Medicine, Faculty of Medicine, Ss. Cyril and Methodius University, Skopje, Republic of Macedonia Department of Nuclear Medicine, Bank of Cyprus Oncology Center, Nicosia, Cyprus.. Department of Nuclear Medicine, Farwania Hospital, Kuwait.. Nuclear Medicine and Molecular Imaging, Apollo Hospitals Dhaka, Society of Nuclear Medicine, Bangladesh (SNMB).. Olivia Newton-John Cancer Research Institute, Heidelberg, Victoria, Australia |
Issue Date: | Jun-2019 | Publication information: | World Journal of Nuclear Medicine 2019; 18(2): 123-126 | URI: | https://ahro.austin.org.au/austinjspui/handle/1/20797 | DOI: | 10.4103/wjnm.WJNM_117_18 | ORCID: | 0000-0001-8641-456X | Journal: | World Journal of Nuclear Medicine | PubMed URL: | 31040741 | ISSN: | 1450-1147 | Type: | Journal Article |
| Appears in Collections: | Journal articles |
Show full item record
Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.